Additionally, there are reports indicating that targeting AURKA effectively inhibits PCa cell proliferation driven by CXCR7, an atypical chemokine receptor up-regulated in PCa following treatment with ADT or ARPIs [133]. This evidence concerns the gene ACKR3 and posterior cortical atrophy.